In Consolidated Inter Partes Reviews, Board Confirms Patentability
ALEXANDRIA, Va. — A challenge to a patented method for treating relapsing-remitting multiple sclerosis (RR-MS) was turned away by the Patent Trial and Appeal Board on July 11, in a win...To view the full article, register now.
Already a subscriber? Click here to view full article